$PLSE News

Needham Initiates Coverage On Pulse Biosciences with Buy Rating, Announces Price Target of $58

Canaccord Genuity Maintains Buy on Pulse Biosciences, Raises Price Target to $43

Pulse Biosciences, Inc. (PLSE) Q2 2026 Earnings Call Transcript

Pulse Biosciences Q2 EPS $(0.36), Inline, Sales $434.000K Miss $533.333K Estimate

Pulse Biosciences, Inc. (PLSE) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Pulse Biosciences, Inc. Announces Planned Redemption of Warrants

Did New Analyst Coverage and Insider Buying Just Shift Pulse Biosciences' (PLSE) Investment Narrative?

Canaccord Genuity Initiates Coverage On Pulse Biosciences with Buy Rating, Announces Price Target of $32

Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026

Here's Why Pulse Biosciences, Inc (PLSE) is a Great Momentum Stock to Buy

Pulse Biosciences CEO Bought 15,000 Company Shares. Here's What That Means for Investors.

Pulse Biosciences, Inc. (PLSE) Presents at Bank of America Global Healthcare Conference 2026 - Slideshow

Pulse Biosciences, Inc. (PLSE) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript

ATM Equity Purchases by Pulse Biosciences’ Co-Chairmen Total Approximately $13.3 Million

Pulse Biosciences Co‑Chairmen, CEO Purchase ~$13.3M In Shares Via ATM Program

Is Pulse Biosciences (PLSE) Quietly Redefining Its Core Identity Around Atrial Fibrillation?

Pulse Biosciences Q1 Earnings Call Highlights

PLSE Q1 2026 Earnings Transcript

Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference

Pulse Biosciences, Inc. (PLSE) Q1 2026 Earnings Call Transcript